首页|肾纤康通过调节Smad3介导的铁死亡缓解CKD小鼠肾纤维化

肾纤康通过调节Smad3介导的铁死亡缓解CKD小鼠肾纤维化

扫码查看
目的:观察肾纤康对单侧输尿管梗阻(unilateral ureteral obstruction,UUO)引起的小鼠肾间质纤维化的缓解效果,并探讨其作用机制.方法:将小鼠随机分为假手术组、模型组、低剂量(150 mg·kg-1·d-1)肾纤康组和高剂量(450 mg·kg-1·d-1)肾纤康组,每组8只.除假手术组外,其余各组均通过单侧输尿管结扎法建立慢性肾脏病(chronic kidney disease,CKD)模型.造模后,分别给予相应剂量的肾纤康,假手术组和模型组则灌胃等体积生理盐水,每天1次,连续7 d.实验结束后,收集小鼠肾脏组织进行苏木精-伊红(hematoxylin-eosin,HE)染色和Masson染色,观察肾脏组织损伤和纤维化程度;利用免疫组化和Western blot技术检测肾脏中纤维化、氧化应激及铁死亡相关蛋白水平的变化;蛋白质免疫共沉淀(co-immunoprecipitation,Co-IP)评估肾纤康对转录激活因子3(activating transcription factor 3,ATF3)与Smad3相互作用的影响.结果:在未经治疗的UUO模型组中,小鼠肾脏出现了如肾小管明显扩张和胶原沉积等典型的病理变化,肾纤康干预组病理改变程度和纤维化明显减轻(P<0.05).在分子层面,肾纤康显著降低了UUO模型组小鼠中Smad3磷酸化水平,以及ATF3、4-羟基壬烯醛(4-hydroxynonenal,4-HNE)和NADPH氧化酶4(NADPH oxidase 4,NOX4)的异常表达,同时增加了谷胱甘肽过氧化酶4(glutathione peroxidase 4,GPX4)和溶质载体家族7成员11(solute carrier family 7 member 11,SLC7A11)表达.Co-IP实验结果表明,肾纤康显著影响了ATF3与Smad3的相互作用.结论:肾纤康有效缓解了UUO引起的小鼠肾间质纤维化,其潜在机制可能涉及对ATF3/Smad3相互作用的调节,进而减轻氧化应激和铁死亡,从而缓解肾脏纤维化.这些发现为肾纤康的进一步研究和临床应用提供了重要的科学依据.
Shen-Xiankang formula alleviates renal fibrosis in chronic kidney disease mice by regulating Smad3-mediated ferroptosis
AIM:To evaluate the therapeutic effect of Shen-Xiankang formula on renal interstitial fibrosis in-duced by unilateral ureteral obstruction(UUO)in mice and to elucidate its underlying mechanisms.METHODS:Thirty-two C57BL/6 mice were randomly divided into sham group,UUO model group,and Shen-Xiankang formula intervention groups receiving either a low dose(150 mg·kg-1·d-1)or a high dose(450 mg·kg-1·d-1),with 8 mice in each group.All mice except those in sham group underwent UUO to establish chronic kidney disease(CKD)model.After modeling,cor-responding doses of Shen-Xiankang or an equivalent volume of saline were administered daily for 7 d.Upon completion of treatment,renal tissues were collected for hematoxylin-eosin(HE)and Masson staining to assess tissue damage and fibro-sis.Immunohistochemistry and Western blot analyses were used to detect the markers of fibrosis,oxidative stress,and fer-roptosis.The effect of Shen-Xiankang formula on the interaction between activating transcription factor 3(ATF3)and Smad3 was assessed using co-immunoprecipitation(Co-IP).RESULTS:The untreated UUO model group exhibited nota-ble pathological changes such as expanded renal tubules and collagen deposition.Shen-Xiankang treatment significantly alleviated these changes(P<0.05).It markedly reduced Smad3 phosphorylation,ATF3,4-hydroxynonenal(4-HNE),and NADPH oxidase 4(NOX4)aberrant expression,while increasing glutathione peroxidase 4(GPX4)and solute carrier family 7 member 11(SLC7A11)expression.Co-IP results indicated a significant modulation of the ATF3-Smad3 interac-tion by Shen-Xiankang.CONCLUSION:Shen-Xiankang formula effectively mitigates UUO-induced renal interstitial fi-brosis in mice.The mechanism may involve modulating the ATF3/Smad3 interaction,which in turn attenuates oxidative stress and ferroptosis,consequently leading to the amelioration of renal fibrosis.These findings provide important insights for further research and clinical application of Shen-Xiankang formula.

Shen-Xiankang formulachronic kidney diseaseferroptosisSmad3 proteinactivating tran-scription factor 3

倪玉芳、张璐娜、张琼、王丽、李健春

展开 >

西南医科大学附属中医医院中西医结合研究中心,四川 泸州 646000

西南医科大学附属中医医院肾病科,四川 泸州 646000

肾纤康 慢性肾脏病 铁死亡 Smad3蛋白 转录激活因子3

国家自然科学基金四川省科技厅项目四川省科技厅项目西南医科大学中西医结合基金

821046652023NSFSC17632022YFS06212023ZYYQ09

2024

中国病理生理杂志
中国病理生理学会

中国病理生理杂志

CSTPCD北大核心
影响因子:1.065
ISSN:1000-4718
年,卷(期):2024.40(6)